Literature DB >> 11172241

The effect of Workers' Compensation on clinical outcomes of arthroscopic-assisted autogenous patellar tendon anterior cruciate ligament reconstruction in an acute population.

G R Barrett1, R T Rook, C R Nash, M R Coggin.   

Abstract

PURPOSE: To assess the effect of Workers' Compensation (WC) benefits on subjective outcomes of patients following anterior cruciate ligament (ACL) reconstruction. TYPE OF STUDY: Prospective study of ACL reconstruction with bone-patellar tendon-bone in an acute population.
METHODS: From October 1991 through June 1997, 1,015 patients underwent ACL reconstruction, 769 with bone-patellar tendon-bone autografts; 235 met the criteria for this study. All chronic injuries, failed and/or bilateral reconstructions were excluded making the total population 139. The final populations included 115 patients in a non-WC group and 24 patients in a WC group. Average follow-up for was 34.5 months for the WC group and 33.6 months for the non-WC group. All patients had equal objective evaluations, which allowed the subjective criteria to be analyzed.
RESULTS: The results revealed a significant difference in the subjective data of patients with WC benefits. Uniformly, WC patients rated subjective criteria as far worse than the non-WC group in postoperative stages. The average of the 15-item visual analog scale showed statistically significant (P <.01) differences between the WC and non-WC groups. Average postoperative Tegner scores were 3.05 for the WC group and 6.02 for the non-WC group, which was statistically significant. The WC group did not return to their preinjury Tegner score.
CONCLUSIONS: The data show that the patients' perception of their knee function drastically differs from the objective findings on examination; therefore, it should be anticipated that the WC patient might have lower subjective outcomes from surgical treatment when compared with their non-WC counterparts.

Entities:  

Mesh:

Year:  2001        PMID: 11172241     DOI: 10.1053/jars.2001.21785

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  7 in total

1.  Young age, female gender, Caucasian race, and workers' compensation claim are risk factors for reoperation following arthroscopic ACL reconstruction.

Authors:  Brian M Capogna; Siddharth A Mahure; Brent Mollon; Matthew L Duenes; Andrew S Rokito
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-12-07       Impact factor: 4.342

2.  Burden of work-related knee disorders in Washington State, 1999 to 2007.

Authors:  June T Spector; Darrin Adams; Barbara Silverstein
Journal:  J Occup Environ Med       Date:  2011-05       Impact factor: 2.162

3.  Efficacy of non-operative treatment of patients with knee arthrofibrosis using high-intensity home mechanical therapy: a retrospective review of 11,000+ patients.

Authors:  Shaun K Stinton; Samantha J Beckley; Thomas P Branch
Journal:  J Orthop Surg Res       Date:  2022-07-06       Impact factor: 2.677

4.  Predictors of short-term recovery differ from those of long-term outcome after arthroscopic partial meniscectomy.

Authors:  Peter D Fabricant; Patricia H Rosenberger; Peter Jokl; Jeannette R Ickovics
Journal:  Arthroscopy       Date:  2008-04-24       Impact factor: 4.772

5.  Ability to return to work without restrictions in workers compensation patients undergoing hip arthroscopy.

Authors:  Simon Lee; Gregory L Cvetanovich; Randy Mascarenhas; Thomas H Wuerz; Richard C Mather; Charles A Bush-Joseph; Shane J Nho
Journal:  J Hip Preserv Surg       Date:  2016-10-27

6.  Workers' compensation status: does it affect orthopaedic surgery outcomes? A meta-analysis.

Authors:  Vinícius Ynoe de Moraes; Katelyn Godin; Marcel Jun Sugawara Tamaoki; Flávio Faloppa; Mohit Bhandari; João Carlos Belloti
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

7.  A comparison of opioid use between WCB recipients and other Manitobans for knee, shoulder, back and carpal tunnel release procedures.

Authors:  Allen Kraut; Colette B Raymond; Okechukwu Ekuma; Leigh Anne Shafer
Journal:  Am J Ind Med       Date:  2016-01-21       Impact factor: 2.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.